Is There an Alternative to PBM Rebates? ICER Paper Examines 3 Options
July 23rd 2019With discussion and debate happening for months in Washington, DC, over drug pricing and the role of pharmacy benefit managers (PBMs), the Institute for Clinical and Economic Review (ICER) published a white paper this week that analyzes 3 possible alternatives to the pharmaceutical rebate system fostered by PBMs.
Read More
Cigna, Express Scripts Capping Insulin Co-Pays at $25 for Participating Commercial Members
July 23rd 2019A day after stakeholders told a House of Representatives subcommittee about problems accessing and paying for insulin, Cigna and its pharmacy benefit manager Express Scripts said they are launching a program for patients with diabetes in their commercial plans so that they pay no more than $25 for a 30-day supply of insulin.
Read More
Insurers Caution Against HRAs for Short-Term Health Plans
January 3rd 2019The health insurance industry cautioned the Trump administration against allowing health reimbursement accounts (HRAs) to be used to purchase short-term limited duration health plans, in comments submitted regarding a proposed rule change.
Read More
California Insurance Commissioner Urges DOJ to Block Aetna, CVS Merger
August 6th 2018The California insurance commissioner, who has spoken out against other large healthcare mergers, this week asked the Department of Justice (DOJ) to block the $69 billion deal combining Aetna with CVS Health.
Read More
Is There a Link Between Asthma and ADHD?
July 31st 2018Both asthma and attention-deficit/hyperactivity disorder (ADHD), both chronic conditions, have been associated with each other in previous studies, but questions remained as to the strength of the association because of other possible confounders.
Read More
Patients with Advanced COPD Less Likely to Receive Palliative Care
June 19th 2018Even though patients with advanced chronic obstructive pulmonary disease (COPD) can suffer from the same distressing symptoms as those with end-stage cancer, they are less likely to receive palliative care than those with other terminal illnesses.
Read More
Denosumab Can Benefit Patients with Glucocorticoid-Induced Osteoporosis
June 11th 2018A study comparing denosumab (Prolia) with risedronate (Actone) found that denosumab could be a useful treatment option for patients newly initiating or continuing glucocorticoids who are at risk of fractures.
Read More
Medicaid Expansion Under ACA Associated With More Positive Than Negative Effects
June 7th 2018A systematic literature review published in Health Affairs found that Medicaid expansion under the Affordable Care Act (ACA) was associated with increases in coverage, service use, quality of care, and Medicaid spending.
Read More